Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries-Reference-Cited by-同舟云学术

Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries

Published:2020-07 Issue:7 Volume:5 Page:e003283
ISSN:2059-7908
Container-title:BMJ Global Health
language:en
Short-container-title:BMJ Glob Health

Author:

Perrin Christophe,Cloez Sandrine,Dujardin Catherine,Ravinetto Raffaella^ORCID

Funder

The survey which inspired this Analysis was funded by the Belgian DGD

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference21 articles.

1. World Health Organization . Global surveillance and monitoring system for substandard and falsified medical products. Geneva: World Health Organization, 2017.

2. World Health Organization . A study on the public health and socioeconomic impact of substandard and falsified products: Executive summary. Geneva: World Health Organization, 2017.

3. World Health Organization . Essential medicines and health products. substandard and falsified (SF) medical products. definitions of substandard and falsified (SF) medical products. Geneva: World Health Organization, 2017. https://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1

4. Global access to quality-assured medical products: the Oxford statement and call to action;Newton;Lancet Glob Health,2019

5. A link between poor quality antimalarials and malaria drug resistance?;Newton;Expert Rev Anti Infect Ther,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review;The Lancet Regional Health - Europe;2021-10

2. Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond;Journal of Pharmaceutical Policy and Practice;2021-05-10